CIGNA INVESTOR DAY

Intensified affordability approach Value-based pharmaceutical programs with specialized clinical support $6,000 Average annual patient savings, inflammatory drug class $1M Average annual client savings, inflammatory drug class High- performing providers 2 Lowering drug costs Target specialty drugs that represent more than half of total drug spend accredo 95% Patients within one hour of specialty pharmacists and nurses Exclusive access to more therapies than the competition 16 Improved: Pricing Utilization Adherence Therapeutic Resource Centers Outcomes 3 Effective sites of care © 2021 Cigna 4 Clinical solutions 29

View entire presentation